A phase I study of intravenous azimexon therapy in human cancer

Y. Z. Patt, Evan M Hersh, J. Reuben, L. Claghorn, G. Mavligit

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)313-318
Number of pages6
JournalJournal of Biological Response Modifiers
Volume5
Issue number4
StatePublished - 1986
Externally publishedYes

Fingerprint

Azirines
Aziridines
Immunologic Adjuvants
Drug Evaluation
Lymphocyte Activation
Hemolysis
Leukocyte Count
Mitogens
Melanoma
T-Lymphocytes
Lymphocyte Count
Neoplasms
Pharmaceutical Preparations
Muromonab-CD3
Poisons
Phytohemagglutinins
Therapeutics
Concanavalin A
Nervous System
Kidney

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

Patt, Y. Z., Hersh, E. M., Reuben, J., Claghorn, L., & Mavligit, G. (1986). A phase I study of intravenous azimexon therapy in human cancer. Journal of Biological Response Modifiers, 5(4), 313-318.

A phase I study of intravenous azimexon therapy in human cancer. / Patt, Y. Z.; Hersh, Evan M; Reuben, J.; Claghorn, L.; Mavligit, G.

In: Journal of Biological Response Modifiers, Vol. 5, No. 4, 1986, p. 313-318.

Research output: Contribution to journalArticle

Patt, YZ, Hersh, EM, Reuben, J, Claghorn, L & Mavligit, G 1986, 'A phase I study of intravenous azimexon therapy in human cancer', Journal of Biological Response Modifiers, vol. 5, no. 4, pp. 313-318.
Patt, Y. Z. ; Hersh, Evan M ; Reuben, J. ; Claghorn, L. ; Mavligit, G. / A phase I study of intravenous azimexon therapy in human cancer. In: Journal of Biological Response Modifiers. 1986 ; Vol. 5, No. 4. pp. 313-318.
@article{76e7b51b716c4000845056bd3114178d,
title = "A phase I study of intravenous azimexon therapy in human cancer",
author = "Patt, {Y. Z.} and Hersh, {Evan M} and J. Reuben and L. Claghorn and G. Mavligit",
year = "1986",
language = "English (US)",
volume = "5",
pages = "313--318",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - A phase I study of intravenous azimexon therapy in human cancer

AU - Patt, Y. Z.

AU - Hersh, Evan M

AU - Reuben, J.

AU - Claghorn, L.

AU - Mavligit, G.

PY - 1986

Y1 - 1986

UR - http://www.scopus.com/inward/record.url?scp=0022974134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022974134&partnerID=8YFLogxK

M3 - Article

C2 - 2874196

AN - SCOPUS:0022974134

VL - 5

SP - 313

EP - 318

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 4

ER -